DENVER, Colo.--(BUSINESS WIRE)--GE Healthcare today announced it has received commitments from more than 100 customers globally for its innovative Alcyone technology, a nuclear cardiology platform combining cadmium zinc telluride (CZT) detectors, focused pin-hole collimation, stationary data acquisition and 3D reconstruction, designed to help facilitate workflow efficiency and dose management while maintaining image quality.
